Media
For press contact, download of press releases,
magazines, reports and more.
Latest news
-
NNE closes 2025 with continued growth and record‑high activity levels
In 2025, NNE delivered on its strategy by executing the largest pharma project portfolio in the company’s history, including some of the most complex pharma projects ever undertaken. The scale and scope of this execution are reflected in the financial results, with sales increasing by 16% to more than DKK 4,500 million and an operating profit margin of 12%.
19 March 2026
-
NNE is recognised as a Børsen Gazelle for the second year in a row
We are thrilled to announce that NNE has been honoured as a Børsen Gazelle Company 2025, marking the second year in a row we recieve this award.
22 January 2026
-
NNE reports strong financial performance for 2024
NNE published its annual report for 2024, showcasing another year of remarkable achievements, financial momentum, and growth. Group sales increased 39%, reaching DKK 4,043 million, with an operating profit margin of 12%. Our group operating profit rose to DKK 502 million, also up 39% from 2023, marking one of our strongest performances to date.
20 March 2025
-
NNE is recognised as a Børsen Gazelle Company 2024
We are thrilled to announce that NNE has been honoured as a Børsen Gazelle Company 2024.
14 October 2024
Keep up with us on social media!
